GRIT and Quangang to Boost Localization of Interleukin-2
Shanghai Grit Biotechnology Co., Ltd. (GRIT) has forged a formal strategic partnership with Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) to leverage both parties' R&D capabilities in innovative T-cell therapy.
T-cell Therapy | 01/06/2024 | By Aishwarya | 324
CBM and Achilles ink come together to develop T - Cell therapies
The Center for Breakthrough Medicines and Achilles Therapeutics are partnering to bring Achilles? therapies to cancer patients in clinical trials.
T Cell Therapy | 14/04/2022 | By Sudeep Soparkar | 532
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy